Literature DB >> 7643971

Multidisciplinary treatment of cerebral arteriovenous malformations.

R Deruty1, I Pelissou-Guyotat, D Amat, C Mottolese, Y Bascoulergue, F Turjman, J P Gerard.   

Abstract

A series of 67 patients treated for cerebral AVM with a multidisciplinary approach is reported. The malformations were classified after the Spetzler Grading Scale, with 67% low-grade and 33% high-grade AVMs. Three modes of treatment were used: surgical resection, endovascular embolization, and radiosurgery (linear accelerator technique). The actual treatment was: surgical resection alone (25% of cases), embolization plus resection (25% of cases), embolization alone (21%) and radiosurgery (30%) either alone (12%), or after incomplete embolization (15%) or after incomplete resection (3%). The clinical outcome was evaluated in terms of deterioration due to treatment. The treatment was responsible for a deterioration in 28% of all patients, either minor deterioration (19%) neurological deficit (4%), or death (4%). All complications of surgical resection (17% of all operated cases) and of radiosurgery (10% of irradiated cases) remained minor. None was haemodynamic-related. After endovascular embolization, a deterioration occurred in 25% of all embolized cases (minor 13%, neurological deficit 5% and death 8%). These complications occurring after embolization were haemodynamic related: ischaemia and haemorrhage (50% for each mechanism). Haemorrhage occurred either during or some days after the embolization procedure. The angiographic eradication rate was: 80% overall, 91% after resection (with or without previous embolization), 87% after radiosurgery (alone or after other techniques), and 10% after embolization alone. The discussion reviews in the literature the general evolution of the management of cerebral AVMs, with successive application of first surgical resection, the embolization and lastly radiosurgery.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1995        PMID: 7643971     DOI: 10.1080/01616412.1995.11740307

Source DB:  PubMed          Journal:  Neurol Res        ISSN: 0161-6412            Impact factor:   2.448


  8 in total

1.  Embolization of arteriovenous malformations prior to radiosurgery.

Authors:  S Miyachi; M Negoro; R Okamoto; G Otsuka; O Suzuki; J Yoshida
Journal:  Interv Neuroradiol       Date:  2001-05-15       Impact factor: 1.610

Review 2.  Surgical management of pediatric cerebral arteriovenous malformations.

Authors:  David Rubin; Alejandro Santillan; Jeffrey P Greenfield; Mark Souweidane; Howard A Riina
Journal:  Childs Nerv Syst       Date:  2010-07-02       Impact factor: 1.475

Review 3.  Endovascular management of arteriovenous malformations of the brain.

Authors:  Charles A Bruno; Philip M Meyers
Journal:  Interv Neurol       Date:  2013-09

4.  Clinical Analysis of 50 Cases of BAVM Embolization with Onyx, a Novel Liquid Embolic Agent.

Authors:  Donglei Song; Bing Leng; Yuxiang Gu; Wei Zhu; Bin Xu; Xiecheng Chen; Liangfu Zhou
Journal:  Interv Neuroradiol       Date:  2005-10-27       Impact factor: 1.610

5.  Endovascular therapy followed by stereotactic radiosurgery for cerebral arteriovenous malformations.

Authors:  Y Arai; Y Handa; H Ishii; Y Ueda; H Uno; T Nakajima; S Hirose; T Kubota
Journal:  Interv Neuroradiol       Date:  2006-06-15       Impact factor: 1.610

6.  Follow-up imaging to detect recurrence of surgically treated pediatric arteriovenous malformations.

Authors:  Shih-Shan Lang; Lauren A Beslow; Robert L Bailey; Arastoo Vossough; Joanna Ekstrom; Gregory G Heuer; Phillip B Storm
Journal:  J Neurosurg Pediatr       Date:  2012-05       Impact factor: 2.375

7.  Multimodality treatment of cerebral AVMs in children: a single-centre 20 years experience.

Authors:  Christian Dorfer; Thomas Czech; Gerhard Bavinzski; Klaus Kitz; Aygül Mert; Engelbert Knosp; Andreas Gruber
Journal:  Childs Nerv Syst       Date:  2009-11-28       Impact factor: 1.475

Review 8.  Endovascular Management of Hemorrhagic Stroke.

Authors:  Basel Musmar; Nimer Adeeb; Junaid Ansari; Pankaj Sharma; Hugo H Cuellar
Journal:  Biomedicines       Date:  2022-01-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.